These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 18520977

  • 1. The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature.
    Gift TL, Blake DR, Gaydos CA, Marrazzo JM.
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S51-60. PubMed ID: 18520977
    [Abstract] [Full Text] [Related]

  • 2. What about the men?
    Dunne EF, Gift TL, Stamm WE.
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S1-2. PubMed ID: 18813144
    [No Abstract] [Full Text] [Related]

  • 3. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
    Gift TL, Gaydos CA, Kent CK, Marrazzo JM, Rietmeijer CA, Schillinger JA, Dunne EF.
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
    [Abstract] [Full Text] [Related]

  • 4. The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling.
    Fisman DN, Spain CV, Salmon ME, Goldberg M.
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S61-5. PubMed ID: 18607306
    [Abstract] [Full Text] [Related]

  • 5. [Chlamydia: from population screening to individual repeated screening].
    Bally F, Quach A.
    Rev Med Suisse; 2014 Oct 08; 10(445):1882, 1884-6. PubMed ID: 25417359
    [Abstract] [Full Text] [Related]

  • 6. [Chlamydia trachomatis infections--a time for action?].
    Mylonas I, Kirschner W, Weissenbacher T, Gingelmaier A, Weissenbacher ER, Friese K.
    Dtsch Med Wochenschr; 2007 May 25; 132(21):1170-6. PubMed ID: 17506013
    [Abstract] [Full Text] [Related]

  • 7. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.
    Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JA, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M, Chlamydia Screening Studies Project Group.
    Health Technol Assess; 2007 Mar 25; 11(8):iii-iv, ix-xii, 1-165. PubMed ID: 17311735
    [Abstract] [Full Text] [Related]

  • 8. The English National Chlamydia Screening Programme: variations in positivity in 2007/2008.
    Simms I, Talebi A, Rhia J, Horner P, French RS, Sarah R, Macintosh M.
    Sex Transm Dis; 2009 Aug 25; 36(8):522-7. PubMed ID: 19455079
    [Abstract] [Full Text] [Related]

  • 9. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
    Postma MJ, Welte R, van den Hoek JA, Jager JC, van Doornum GJ, Coutinho RA.
    Ned Tijdschr Geneeskd; 1999 Nov 20; 143(47):2383-5. PubMed ID: 10590778
    [Abstract] [Full Text] [Related]

  • 10. Chlamydia trachomatis positivity rates among men tested in selected venues in the United States: a review of the recent literature.
    Rietmeijer CA, Hopkins E, Geisler WM, Orr DP, Kent CK.
    Sex Transm Dis; 2008 Nov 20; 35(11 Suppl):S8-S18. PubMed ID: 18449072
    [Abstract] [Full Text] [Related]

  • 11. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE, Wu O, Twaddle S, Macmillan S, McMillan L, Templeton A, McKenzie H, Noone A, Allardice G, Reid M.
    BJOG; 2004 Nov 20; 111(11):1261-8. PubMed ID: 15521872
    [Abstract] [Full Text] [Related]

  • 12. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
    Gillespie P, O'Neill C, Adams E, Turner K, O'Donovan D, Brugha R, Vaughan D, O'Connell E, Cormican M, Balfe M, Coleman C, Fitzgerald M, Fleming C.
    Sex Transm Infect; 2012 Apr 20; 88(3):222-8. PubMed ID: 22213681
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR, Gaydos CA, Quinn TC.
    Sex Transm Dis; 2004 Feb 20; 31(2):85-95. PubMed ID: 14743071
    [Abstract] [Full Text] [Related]

  • 14. Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data.
    de Vries R, van Bergen JE, de Jong-van den Berg LT, Postma MJ, PILOT-CT Study Group.
    Value Health; 2006 Feb 20; 9(1):1-11. PubMed ID: 16441519
    [Abstract] [Full Text] [Related]

  • 15. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Coutinho RA, Jager JC.
    Ned Tijdschr Geneeskd; 1999 Mar 27; 143(13):677-81. PubMed ID: 10321301
    [Abstract] [Full Text] [Related]

  • 16. Laboratory aspects of screening men for Chlamydia trachomatis in the new millennium.
    Gaydos CA, Ferrero DV, Papp J.
    Sex Transm Dis; 2008 Nov 27; 35(11 Suppl):S45-50. PubMed ID: 18449069
    [Abstract] [Full Text] [Related]

  • 17. Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies.
    Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mårdh PA, Stary A, Stray-Pedersen B.
    Sex Transm Infect; 2002 Dec 27; 78(6):406-12. PubMed ID: 12473799
    [Abstract] [Full Text] [Related]

  • 18. The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia.
    Walleser S, Salkeld G, Donovan B.
    Sex Health; 2006 Dec 27; 3(4):225-34. PubMed ID: 17112432
    [Abstract] [Full Text] [Related]

  • 19. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN.
    Ned Tijdschr Geneeskd; 1999 May 08; 143(19):1012. PubMed ID: 10368724
    [No Abstract] [Full Text] [Related]

  • 20. The utility and cost of Chlamydia trachomatis and Neisseria gonorrhoeae screening of a male infertility population.
    Domes T, Lo KC, Grober ED, Mullen JB, Mazzulli T, Jarvi K.
    Fertil Steril; 2012 Feb 08; 97(2):299-305. PubMed ID: 22192351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.